Accessibility Menu
 
Innovation Pharmaceuticals logo

Innovation Pharmaceuticals

(OTC) IPIX

Current Price$0.00
Market Cap$161,200
Since IPO (2007)-100%
5 Year-100%
1 Year+200%
1 Month+0%

Innovation Pharmaceuticals Financials at a Glance

Market Cap

$161,200

Revenue (TTM)

$6.00K

Net Income (TTM)

$2.65M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

6.80 (High)

Price

$0.00

Volume

202,100

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.05

IPIX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Innovation Pharmaceuticals

Industry

Biotechnology

Employees

4

CEO

Leo Ehrlich, CPA

Headquarters

Wakefield, MA 01880, US

IPIX Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

-1%

Return on Assets

-42%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-2.71%

Stock Overview

Market Cap

$161.20K

Shares Outstanding

537.28M

Volume

202.10K

Avg. Volume

122.37K

Financials (TTM)

Gross Profit

$373.00K

Operating Income

$3.11M

EBITDA

$2.74M

Operating Cash Flow

$2.11M

Capital Expenditure

$60.00K

Free Cash Flow

$2.17M

Cash & ST Invst.

$1.52M

Total Debt

$725.00K

Innovation Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2024YOY CHG

Revenue

$0.00

N/A

Gross Profit

$88.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$161.20K

N/A

Market Cap/Employee

$40.30K

N/A

Employees

4

N/A

Net Income

$880.00K

+38.4%

EBITDA

$772.00K

+41.5%

Quarterly Fundamentals

Name
Q1 2024YOY CHG

Net Cash

$626.00K

-75.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$457.00K

-41.9%

Short Term Debt

$238.00K

-47.1%

Return on Assets

-42.14%

N/A

Return on Invested Capital

-1.25%

N/A

Free Cash Flow

$679.00K

+14.6%

Operating Cash Flow

$677.00K

+14.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDINMedGen, Inc.
$0.00+0.00%
LFCOFLift & Co. Corp.
$0.00+0.00%
RGRXRegeneRx Biopharmaceuticals, Inc.
$0.00+0.00%
WSNAFWesana Health Holdings Inc.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$15.47+0.09%
FFord Motor Company
$14.93+0.09%
AALAmerican Airlines Group
$13.85+0.02%
NIONio
$5.20-0.07%

Questions About IPIX

What is the current price of Innovation Pharmaceuticals?

Innovation Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Innovation Pharmaceuticals?

Over the past 52 weeks, Innovation Pharmaceuticals has traded between $0.00 and $0.05.

How much debt does Innovation Pharmaceuticals have?

As of the most recent reporting period, Innovation Pharmaceuticals reported total debt of $725,000.

How much cash does Innovation Pharmaceuticals have on hand?

Innovation Pharmaceuticals reported $1.52M in cash and cash equivalents in its most recent financial results.

What is Innovation Pharmaceuticals’s dividend yield?

Innovation Pharmaceuticals does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.